Science Explorer Interactive view Map
Company · Lexington · United States

ImmuneXcite (United States)

immunexcite.comROR OpenAlex
Research works
2
▼ 100% vs 2013–17
Citations
0
0.0 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
80%
world 28%

Not ranked overall: ImmuneXcite (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does ImmuneXcite (United States) publish most on?

By volume: Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Nanoplatforms for cancer theranostics and Immunotherapy and Immune Responses.

Immune cells in cancer1Immune cells in cancer: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCancer Research and Treatments: 0 fractional works
ImmunologyOncologyBiomedical EngineeringBiotechnology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune cells in cancer Immunology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Cancer Research and Treatments Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available80.0%not open20.0%

World: 28% of research is openly available.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.